ABSTRACT: Maternal nutrient restriction leads to alteration in fetal adipose tissue, and offspring from obese mothers have an increased risk of developing obesity. We hypothesized that maternal obesity increases fetal adipogenesis. Multiparous ewes (Columbia/Rambouillet cross 3 to 5 yr of age) carrying twins were assigned to a diet of 100% (Control; CON; n = 4) or 150% (Obese; OB, n = 7) of NRC maintenance requirements from 60 d before conception until necropsy on d 135 of gestation. Maternal and fetal plasma were collected and stored at −80ºC for glucose and hormone analyses. Fetal measurements were made at necropsy, and perirenal, pericardial, and subcutaneous adipose tissues were collected from 7 male twin fetuses per group and snap frozen at −80ºC. Protein and mRNA expression of fatty acid translocase [cluster of differentiation (CD) 36], fatty acid transport proteins (FATP) 1 and 4, insulin-sensitive glucose transporter (GLUT-4), fatty acid synthase (FASN), and acetyl-coA carboxylase (ACC) was evaluated. Fetal weight was similar, but fetal carcass weight (FCW) was reduced (P < 0.05) in OB versus CON fetuses. Pericardial and perirenal adipose tissue weights were increased (P < 0.05) as a percentage of FCW in OB versus CON fetuses, as was subcutaneous fat thickness (P < 0.001). Average adipocyte diameter was greater (P < 0.01) in the perirenal fat and the pericardial fat (P = 0.06) in OB fetuses compared with CON fetuses. Maternal plasma showed no difference (P > 0.05) in glucose or other hormones, fetal plasma glucose was similar (P = 0.42), and cortisol, IGF-1, and thyroxine were reduced (P ≤ 0.05) in OB fetuses compared with CON fetuses. Protein and mRNA expression of CD 36, FATP 1 and 4, and GLUT-4 were increased (P ≤ 0.05) in all fetal adipose depots in OB versus CON fetuses. The mRNA expression of FASN and ACC was increased (P < 0.05) in OB vs. CON fetuses in all 3 fetal adipose tissue depots. Fatty acid concentrations were increased (P = 0.01) in the perirenal depot of OB versus CON fetuses, and specifi c fatty acid concentrations were altered (P < 0.05) in subcutaneous and pericardial adipose tissue because of maternal obesity. In conclusion, maternal obesity was associated with increased fetal adiposity, increased fatty acid and glucose transporters, and increased expression of enzymes mediating fatty acid biosynthesis in adipose depots. These alterations, if maintained into the postnatal period, could predispose the offspring to later obesity and metabolic disease.
INTRODUCTION
Epidemiological evidence suggests that obesity and other chronic diseases may be programmed during fetal life Ford et al., 2007; Long et al., 2011) . In precocial species such as sheep and humans, adipogenesis and lipogenesis occur predominantly before birth (Greenwood et al., 1998) . Fetal fat mass can be signifi cantly altered through changes in maternal di-etary energy intake, which subsequently affects nutrient availability to the fetus and fetal and neonatal adiposity (Reed et al., 2007; Meyer et al., 2010) . However, the role of fatty acids transporters in fetal adipose tissue development is unknown. Long-chain fatty acids in maternal circulation are taken up by fetal tissue, and this is mediated by a family of transmembrane fatty acid transport proteins including fatty acid transporters (FATP; 1 and 4), fatty acid binding proteins (FABP), and fatty acid translocase (CD 36; Stahl et al., 2001; Wu et al., 2006; Nickerson et al., 2009) .
We have developed an ovine model of maternal obesity induced by excess dietary intake in which fetal weight is increased ~30% by mid-gestation in combination with increased fetal circulating concentrations of glucose, insulin, and IGF-1 compared with fetuses from ewes fed only to requirements Zhu et al., 2009 ). In addition, FATP were upregulated in placentae obtained at midgestation and late gestation from these obese ewes compared with ewes fed to requirement and were positively associated with increased maternal and fetal circulating triglycerides, cholesterol, and lipoproteins . Newborn lambs from obese ewes on this experimental paradigm had similar birth weights but greater adiposity compared with newborn lambs from ewes fed to requirements ). Our hypotheses was that maternal obesity leads to increases in fetal adipose tissue mass through increased lipogenesis or increased transport of fatty acids into fetal adipocytes.
MATERIALS AND METHODS
All animal procedures were approved by the University of Wyoming Animal Care and Use Committee.
Animals and Tissue Collection
Major details have been described previously by Ford et al. (2009) with ration composition given by Zhu et al. (2008) . Briefl y, from 60 d before conception (d 0) to d 135 of gestation, multiparous ewes (Rambouillet/ Columbia cross, 3 to 5 yr of age) were fed a diet at 100% of NRC recommendations (1985) for energy based on metabolic BW of individual ewes (control, CON) or 150 % of NRC requirements (obese, OB). Weekly BW were collected for each ewe and rations were adjusted for increases in BW. All ewes consumed 100% of their daily ration. Additionally, a BCS (Sanson et al., 1993; Ford et al., 2009 ) was determined for each ewe immediately before breeding, at midgestation (d 65 to 79 of gestation), and at late gestation (d 115 to 130 of gestation) by averaging the scores (1 to 9 scale, with 1 being emaciated and 9 being extremely obese) assigned by the same 2 trained individuals. The number of fetuses carried by each ewe was determined by ultrasonography (Asonics Microimager 1000 sector scanning instrument, Ausonics Pty Ltd., Sydney, Australia) on d 45 of gestation. Only CON ewes (n = 4) and OB ewes (n = 7) carrying twin fetuses were assigned to this study.
The OB ewes have almost a 6 d shorter gestation length (Long et al., 2010a) ; therefore, d 135 was chosen as the late gestation necropsy date to prevent the endocrine changes associated with parturition from affecting the results. Before necropsy on d 135 of gestation, each ewe was weighed and a sample of blood (~10 mL) collected via jugular venipuncture into a chilled vacutainer tube (Sodium Heparin; Sigma, St. Louis, MO), and plasma was collected by centrifugation at 2500 × g for 15 min at 4°C, and was frozen at −80°C for subsequent insulin, cortisol, and IGF-1 quantitation. A separate chilled vacutainer tube (Heparin plus sodium fl uoride; 2.5 mg/mL; Sigma) was also collected and plasma was collected as previously described and was stored at −80°C for glucose analysis. Ewes were then sedated with ketamine (10 mg/kg BW) and maintained under isofl uorane inhalation anesthesia (2.5%). Immediately after laparotomy, umbilical vein blood (~15 ml) was collected from 7 randomly selected male fetuses gestated by CON ewes and 7 randomly selected male fetuses from OB ewes as previously described , and plasma was collected as previously described and then was frozen and stored at −80°C. Fetuses and ewes were euthanized by exsanguination while still under general anesthesia and the gravid uterus was removed quickly. Fetal weights and crown rump lengths of male fetuses were determined and fetal perirenal and pericardial adipose depots were quickly removed and weighed. Subcutaneous adipose tissue thickness was measured at the 12th rib on the right side of each fetus using calipers. Adipose tissues were either collected for histology (see below) or fl ash frozen in liquid nitrogen and stored at −80°C. Subcutaneous adipose tissue was dissected from the skin on the left side of the fetus and frozen at −80ºC. The method utilized for collection, along with the small amount of subcutaneous adipose tissue collected, precluded histologic evaluation.
Histological Procedures
Samples of fetal adipose tissue from the perirenal and pericardial depots were fi xed in 4% paraformaldehyde, embedded in paraffi n, and sectioned at 10 μm using a MICROM HM310 microtome (MICROM Inc., Walldorf, Germany) to obtain 6 sections for evaluation that were 10 sections apart from each other. Sections were deparaffi nized and then stained using Harris Modifi ed Hematoxylin (Fisher Scientifi c, Fair Lawn, NJ) and Eosin Y (EMD Chemicals, Gibbstown, NJ). Images were visualized using an Olympus BX50 microscope (Olympus, Center Valley, PA) and captured digitally using a Retiga EXiFast camera. Pictures at 200× magnification were taken using QED Imaging software (Media Cybernetics, Silver Spring, MD). Five randomly chosen fi elds were taken per section for a total of 30 pictures per fetal adipose depot. Pictures were randomly selected for analysis and 2 fi elds per section were analyzed for cell diameter by 1 trained investigator blinded to treatment. Cell diameter was calculated from all whole adipocytes per fi eld area. At least 1,200 adipocytes per fetal adipose depot were measured. Image analysis was done using Image J Software (NIH, Bethesda, MD).
Western Blotting
Western blotting analysis was conducted where acceptable commercial antibodies were available using our previously published procedures (Zhu et al., 2007 . Briefl y, protein was extracted from ~100 mg of pulverized perirenal, pericardial, or subcutaneous adipose tissue using ice-cold lysis buffer and a homogenizer (polytron). The homogenates were sonicated and clarifi ed by centrifugation. The supernatant was mixed with 2× SDS sample loading buffer and heated to 95°C for 5 min. Protein extracts were separated on 5 to 15 % SDS-PAGE gels and transferred to nitrocellulose membranes for immunoblotting. Rabbit anti-FATP 1 (Cat # sc-25541), FATP 4 (Cat # sc-25670), CD 36 (Cat # sc9154), and goat anti-insulin-sensitive glucose transporter (GLUT-4; SC-1606) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) and used as primary antibodies at a dilution of 1:500, 1:500, 1:200, and 1:500, respectively. Anti-goat IgG antibody (Cat # sc2020) was purchased from Santa Cruz Biotechnology, Inc., and anti-rabbit IgG (Cat # 7074) was purchased from Cell Signaling Technology, Inc. (Danvers, MA) and used as second antibodies at a dilution of 1:2,000. Band density was normalized according to the β-actin content (β-actin antibody, Cat # 4967 Cell Signaling Technology, Inc. at a dilution of 1:1,000).
Total RNA Extraction and Real-time PCR
Total RNA was extracted from ~200 mg of pulverized fetal adipose tissue using Trizol reagent (Invitrogen Corp., Carlsbad, CA) and then purifi ed by RNeasy mini column (QIAGEN Inc., Valencia, CA). One microgram of RNA was used to synthesize single-stranded DNA using QuantiTect Reverse Transcription System (QIAGEN, Inc.) according to the supplied protocol. Primer sequences for CD 36, FATP 1, FATP 4, FABP 1, FABP 2, FABP 4 , and FABP 5 have been previously published by , GLUT 4 by Long et al. (2010b) , and fatty acid synthase (FASN) and acetyl-coA carboxylase (ACC) by Ducket et al. (2009) . Quantifi cation of gene expression for the 10 genes was expressed relative to 18S rRNA as previously described (Lomax et al., 2007) . Cycle threshold values for 18S rRNA were similar (P > 0.35) within an adipose tissue depot.
Fatty Acid Extraction and Analysis
Fatty acid (FA) composition of fetal adipose depots was determined by GLC as outlined by Murrieta et al. (2003) . Briefl y, 1 mL of a 1.0-mg/mL internal standard solution of tri13:0 (glyceryl-tritridecanoate, Sigma) in chloroform was added to individual 16-× 125-mm tubes and was dried under nitrogen. Then ~100-mg samples of pulverized fetal adipose tissue were added to a standardized tube in duplicate. Fatty acid methyl esters were prepared using direct transesterifi cation with 0.2 N KOH in methanol (Murrieta et al., 2003) . Fatty acid methyl esters from fetal adipose tissue were separated using an Agilent 6890 GLC (Agilent Technologies, Inc., Palo Alto, CA) equipped with a 100-m × 0.25-mm fused silica capillary column (SP-2560, 0.2-μm fi lm thickness; Supelco, Bellefonte, Pa) and fl ame ionization detector. Fatty acid methyl ester peaks were identifi ed by comparing retention times with fatty acid methyl esters standards (Nu-Check Prep, Inc, Elysian, MN, and Matreya, Inc, Pleasant Gap, PA). Fatty acid methyl esters were evaluated using ChemStation software (Agilent Technologies, Inc.). Total fatty acid and specifi c fatty acid concentrations were determined according to Murrieta et al (2003) .
Hormone and Metabolite Quantifi cation
Glucose was measured colorimetrically in triplicate (Liquid Glucose Hexokinase Reagent, Pointe Scientifi c, Inc., Canton, MI) as previously described . Mean intra-assay CV was 0.6 % and inter-assay CV was 2.3 %. Insulin was measured in duplicate by commercial RIA ; Siemens Medical Solutions Diagnostics, Los Angeles, CA) within a single assay with an intra-assay CV of 8.8 %, and a sensitivity of 0.10 ng/mL. Concentrations of cortisol were determined as described previously by Dong et al. (2008) using Coat-A-Count Cortisol RIA with a sensitivity of 0.5 μg/dL (Siemens Medical Solutions Diagnostics) in a single assay with an intra-assay CV of 4.7%. Tri-iodothyronine (T3) and thyroxine (T4) were determined by RIA according to manufacturer's specifi cations (Coat-a-Count Total T3 and T4, Siemens Medical Solutions Diagnostics) and previously published from our laboratory (Vonnahme et al., 2003) . For each analyte, samples were evaluated in a single assay. The intra-assay CV was 7.1 % and 6.6 % for T3 and T4, respectively. Plasma IGF-1 was mea-sured on an Immulite 1000 (Siemens Medical Solutions Diagnostics) in a single assay and previously validated for sheep . The sensitivity of the IGF-1 assay was 20 ng/mL and had an intra-assay CV of 2.1%.
Statistical Analysis
We know that fetal sex has effects on fetal weight at late gestation in this fl ock ; therefore, only male fetuses from ewes caring twins were utilized for analysis to reduce variation. Data were analyzed as a completely randomized design using the GLM procedure (SAS Inst., Inc., Cary, NC). Ewe was initially included as a covariate in all fetal analysis to investigate specifi c ewe effects of each fetus and was found to be non-signifi cant (P > 0.19). Therefore, ewe was removed, leaving treatment only in the model. Means separation was performed using the LSMEANS statement with the PDIFF option. Data were reported as least squares means ± SEM and considered signifi cantly different when P ≤ 0.05 and a tendency was indicated when P ≤ 0.10.
RESULTS

General Ewe and Fetal Morphometrics
Ewes on both CON and OB treatments started the study with a similar BW (73.0 ± 3.7 vs. 70.7 ± 2.8 kg, respectively). However, at breeding, OB ewes had greater (P < 0.05) BW and BCS compared with CON ewes (85.5 ± 3.2 kg and 6.6 ± 0.2 BCS vs. 70.1 ± 3.6 kg and 5.2 ± 0.3 BCS, respectively). During late gestation, this difference between OB and CON ewes was increased (P < 0.0001; 116.2 ± 3.4 kg and 7.8 ± 0.2 BCS vs. 89.6 ± 3.9 kg and 6.1 ± 0.3 BCS, respectively). Fetal weights and weights of selected tissues of twin male fetuses at d 135 of gestation are shown in Table 1 . There was no difference in fetal weight between the 2 groups (P > 0.05). However, fetal carcass weight was reduced (P < 0.05) in OB vs. CON fetuses ( Table 1) . Weight of perirenal and pericardial fat depots and thickness of subcutaneous fat over the 12th rib are shown in Table 1 . Maternal obesity had no effect (P ≥ 0.47) on absolute depot weights, but it increased (P < 0.05) the weight of the perirenal and pericardial depots relative to carcass weight. Subcutaneous fat thickness was almost doubled (P < 0.05) in OB fetuses compared with CON fetuses. Average adipocyte diameter was 35.72 ± 1.26 μm in the perirenal fat of CON fetuses and 42.06 ± 1.18 μm in OB fetuses (P < 0.01). Similarly, average adipocyte diameter tended to be greater (P = 0.06) in the pericardial adipose tissue of OB fetuses compared with CON fetuses (39.6 ± 1.2 vs. 37.1 ± 1.0 μm). Size distribution of adipocytes in perirenal and pericardial adipose tissue depots are given in Figure 1 . Perirenal adipose tissue adipocyte diameter distribution was shifted in the positive direction in OB fetuses compared with CON fetuses, further supporting the difference in mean adipocyte diameter. In pericardial adipose tissue, adipocytes from 40.0 to 59.9 μm were increased (P = 0.01) in the OB fetuses compared with CON fetuses, while the adipocytes <20 μm were increased (P < 0.05) in CON fetuses compared with OB fetuses.
Maternal and Fetal Plasma Concentrations of Metabolites and Hormones
Maternal and fetal plasma concentrations of metabolites and hormones on d 135 of gestation are given in Table 2 . Maternal plasma insulin, cortisol, IGF-1, and T3 were similar (P > 0.20) between CON and OB ewes at necropsy at d 135 of gestation. Plasma concentrations of glucose in OB ewes tended to be greater (P = 0.10) than that of CON ewes. In fetal plasma, concentrations of glucose and insulin were also similar (P > 0.42) between OB and CON fetuses. Plasma concentrations of cortisol, IGF-1, and T4 were reduced (P ≤ 0.05) in fetuses from OB ewes compared with fetuses from CON ewes. Triiodothyronine was only detectable (>10 ng/dL) in 2 fetuses per treatment group. Therefore, it was deemed nondetectable in both groups of fetuses.
Fetal Adipose Tissue Transporters and FASN and ACC Abundance
Effi ciency of amplifi cation for all primers ranged from 1.85 to 2.15. Messenger RNA expression for CD 36, FATP 1 and 4, GLUT 4, and FABP for the 3 adipose depots are shown in Figure 2 . The mRNA expression of CD 36, FATP 1 and 4, and GLUT 4 in all 3 adipose depots was increased (P < 0.05) in OB fetuses compared with CON fetuses. Fatty acid binding proteins were unaffected by maternal dietary treatment in all depots except subcutaneous adipose tissue, where OB fetuses had increased (P < 0.05) mRNA expression of FABP 1 and 5 compared with CON fetuses. Consistent with the mRNA changes, protein content of CD 36, FATP 1, FATP 4, and GLUT 4 were increased (P < 0.05) in all 3 adipose de- Subcutaneous fat thickness, mm 0.5 ± 0.1 0.9 ± 0.1 0.01 pots of fetuses from OB ewes compared with CON ewes (Figure 3) . Messenger RNA expression of FASN and ACC are shown in Figure 4 for all adipose tissue depots. Messenger RNA expression of FASN was increased (P < 0.01) in all depots in fetuses from OB ewes compared with fetuses from CON ewes. Messenger RNA expression for ACC was increased (P < 0.05) in all fetal adipose depots in OB fetuses compared with CON fetuses.
Adipose Tissue Depot Fatty Acid Composition
Perirenal, pericardial, and subcutaneous adipose tissue fatty acid concentrations in fetuses from OB and CON ewes are given in Table 3 . Total fatty acid concentrations in perirenal adipose tissue were increased (P = 0.01) in fetuses from OB ewes compared with fetuses from CON ewes. This was associated with increased (P ≤ 0.04) concentrations of 18:0, 18:1 c-9, and 18:1 c-10/c11 in OB fetuses compared with CON fetuses in the perirenal adipose depot. In the pericardial adipose depot, there was no difference (P = 0.21) in total fatty acid concentrations between CON and OB fetuses. Only 18:1 c-9 was increased (P = 0.05) and 18:1 c-10/11 tended to be increased (P = 0.07) in the pericardial adipose tissue of fetuses from OB ewes compared with fetuses from CON ewes. While total fatty acids in subcutaneous adipose tissue were numerically twice as abundant in OB fetuses compared with CON fetuses, the variation between fetuses resulted in only a trend (P = 0.09). However, concentrations of 16:0, 18:1 c-9, and 20:4 n-6 (arachidonic acid) in fetuses from OB ewes were increased (P < 0.03) compared with fetuses from CON ewes.
DISCUSSION
To our knowledge, this is the fi rst report to evaluate fetal adipose tissue mass and adipocyte morphology in an ovine model of maternal obesity and nutrient excess that is initiated before pregnancy and continues throughout pregnancy thereby closely addressing the common situation in human pregnancy. In addition, the data show changes in adipose tissue fatty acid transporters, fatty acid concentrations, and lipogenic enzymes mRNA expression associated with maternal obesity and nutrient intake. The increased adiposity seen in the d-135 fetuses is consistent with our published fi ndings in newborn lambs from obese mothers that had similar birth weights but an increased percentage of body fat compared with lambs from control mothers . Maternal obesity increased the amount of adipose tissue in perirenal, pericardial, and subcutaneous fat depots in the late gestation fetus as a percentage of fetal carcass weight. The lack of absolute differences in fetal perirenal adipose tissue has been observed when ewes were fed 155% of NRC requirements from d 103 to 120 of gestation (Muhlhausler et al., 2003) . The major difference in fetal body composition we observed as a result of maternal over-nutrition throughout pregnancy was that late gestational fetal carcass weight was reduced in our model of maternal obesity, and nutrient excess and fat depots were increased as a percentage of fetal carcass weight. Fetal carcass weight is a reliable indicator of lean muscle mass because it refl ects primarily skeletal muscle and bone, and all organs have been removed. The reduction in muscle mass in late gestation was supported by a reduction in skeletal muscle myogenesis observed at d 75 of gestation in our model of maternal obesity (Tong et al., 2009) . The increased fetal subcutaneous adipose tissue thickness has not been reported in any other model of fetal programming either using maternal nutrition or other means of altering fetal growth. The differences in subcutaneous adipose tissue thickness were not expected because subcutaneous adipose tissue is the last depot to develop in the ovine fetus (Gemmell and Alexander, 1978; Vernon, 1986) . The importance of this difference in subcutaneous adipose tissue mass is that this adipose depot is exclusively white adipose tissue (Gemmell and Alexander, 1978) .
The use of each individual fetus as the experimental unit in twin pregnancies is controversial. Each fetus has its own placenta. Therefore, it is reasonable to assume that each fetus can interact independently with the maternal environment. The other main reason that only male fetuses were used is that male and female fetuses are not of similar size in late gestation in this fl ock . Therefore, averaging twins of different sexes together compared with twins of the same sex does not accurately represent the fi nding resulting from an analysis of the fetuses as separate experimental units. Further, our laboratory has published several refereed papers where this argument was used , Zhang et al., 2011 . However, to address whether the ewe infl uences the data reported, we analyzed all the fetal data with ewe as a covariate and found that it was non-significant. The authors realize that this is not a perfect way of addressing this issue but feel that it adds evidence to support our point of view. We realize that this question is still unresolved among researchers working in fetal physiology but hope this helps readers understand the discussion and reasoning behind using male fetuses from twin pregnancies as our experimental unit.
At midgestation, fetal weights were 30% greater in obese fetuses than control fetuses ). However, from midgestation to late gestation, there was a slowing of fetal growth that resulted in similar fetal weights at d 135 of gestation. As previously reported, this slowing in fetal growth was a result of reduced placental vascularity and angiogenic factor production in these obese pregnancies . At midgestation, obese fetuses have increased plasma concentrations of glucose, insulin, cortisol, and IGF-1 compared with control fetuses (Ford et al., 2009 ), while T4 concentrations at midgestation were similar (CON 1.4 ± 0.1 vs. OB 1.6 ± 0.1 μg/dL) between control and obese fetuses (S. P. Ford, unpublished observations). At term, glucose and cortisol were increased and plasma insulin was reduced in obese newborn lambs born to obese ewes compared with lambs born to control-fed ewes , Zhang et al., 2011 . These differences likely refl ect the rapidly changing regulatory and feedback systems involved in the preparation for independent extra-uterine life. The roles of insulin, IGF-1, and thyroid hormones in adipocyte differentiation have been thoroughly reviewed (Hausman et al., 2009) . It is possible that the increased hormone and metabolite concentration at midgestation in OB fetuses could have lead to the differences in adipose tissue mass and composition observed at late gestation in the present study. The reduction in IGF-1 would explain some of the reduction in fetal growth from midgestation to late gestation in the fetuses from OB ewes.
The placentas of obese ewes contain increased abundance of FATP at both mid and late gestation that would result in increased transport of lipid into the fetal circulation . Therefore, it is possible that the increased adipose tissue expression of FATP observed in this study was due to increased lipids in the fetal circulation. Similarly, GLUT 4 could be upregulated and expressed to a greater extent in the fetuses of OB ewes because of the increased plasma glucose concentrations seen at midgestation. Glucose transporter 4 abundance has been shown to be affected by fetal glucose and insulin concentrations (Hay, 2006) . Another possible explanation for the increased adipose tissue nutrient transporters is that these transporters are associated with changes in adipocyte maturation. Exogenous fatty acids along with hormones have been shown to increase adipocyte differentiation in preadipocytes cultured from chickens (Matsubara et al., 2005) . This is further supported by the observation that membrane uptake of radiolabeled long-chain fatty acids is increased during adipocyte differentiation (Abumred et al., 1991) . This transmembrane transport of long-chain fatty acids is most likely carried out by FATP and CD 36. Glucose transporter 4 has been shown to play an important role in the adipocyte maturation process, and GLUT 4 expression increases as preadipocytes differentiate, which is regulated by C/EBP (Kaestner et al., 1990) . Maternal under nutrition during early to mid gestation in the ewe results in altered fetal adipose tissue development at late gestation (Bispham et al., 2003) . Even more interesting, genetics (breed of cattle) can infl uence fetal adipocyte metabolism and cellularity, indicating changes in adipose tissue maturity at late gestation (Taga et al., 2011) . Therefore, maternal obesity and resulting changes in fetal plasma lipid content are able to alter fetal adipose tissue nutrient transporters. These changes are associated with altered maturity of the adipose tissue.
The altered fatty acid composition of fetal adipose tissue in OB fetuses compared with fetuses gestated by CON ewes could indicate alterations in fatty acid synthesis. There were greater concentrations of lipids in adipose tissue from OB fetuses compared with CON fetuses in the perirenal adipose depot, which is the fi rst adipose depot to form in ovine fetuses (Broad et al., 1980; Vernon, 1986) . In subcutaneous adipose tissue, the last fetal adipose depot to form (Broad et al., 1980; Vernon 1986) , there was only a trend for an increase in fatty acids in OB fetuses compared with CON fetuses. The alteration in specifi c fatty acids in the OB fetal adipose tissue would indicate altered fatty acid synthesis. This is suggested because the fatty acid biosynthesis pathway terminates with a 16-carbon fatty acid, which can then be immediately elongated to 18-carbon fatty acids, and then desaturated into 18:1 c-9. In the specifi c fatty acid concentrations in the adipose tissue from OB fetuses, we observed increased concentrations of the fatty acids 16:0, 18:0, and the 18:1 isomers. These could indicate increased fatty acid synthesis, with the increased 16:0 fatty acid produced being immediately transformed into the 18:0 and 18:1 fatty acids that we found increased in the adipose tissue of OB fetuses. This idea is further supported by the greater mRNA expression of FASN and ACC, both major rate-limiting enzymes of fatty acid synthesis, in the OB fetuses compared with CON fetuses. These data suggest that the rate of fatty acid synthesis is increased in OB fetal adipose tissues, as a result of increased fatty acid composition and expression of enzymes mediating fatty acid biosynthesis. This is consistent with data from adult offspring derived from this paradigm. When these offspring were placed on a 12-wk ad libitum feeding trial, we found markedly increased body fat at the end of the feeding challenge in OB compared with CON offspring, suggesting that increased fatty acid synthesis persisted into the postnatal period (Long et al., 2010a) .
In conclusion, maternal obesity and high nutrient intake before conception and continuing throughout gestation is associated with increased fetal adiposity at late gestation. This fetal adiposity is associated with elevated protein and mRNA abundance of nutrient transporters. In addition, maternal obesity is associated with elevated concentrations of total and specifi c fatty acids in fetal adipose tissue that could indicate increased fatty acid synthesis within this adipose tissue. These alterations in fetal adipose tissue function could lead to the increased adiposity and insulin resistance seen in adult offspring from this model of maternal obesity when fed ad libitum (Long et al., 2010a) and predispose these offspring to further metabolic diseases in later life.
